Nuvilex Shares to Reverse Split on Friday, November 13th (NASDAQ:PMCB)

Nuvilex Inc. (NASDAQ:PMCB)’s stock is set to reverse split on the morning of Friday, November 13th. The 1-19 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, November 12th.

Nuvilex Trading Up 0.8%

NASDAQ:PMCB traded up $0.00 during mid-day trading on Thursday, hitting $0.40. The company had a trading volume of 398,300 shares, compared to its average volume of 199,711. The business has a fifty day simple moving average of $0.40 and a 200-day simple moving average of $0.62. The firm has a market capitalization of $4.32 million, a price-to-earnings ratio of -0.17 and a beta of 0.78. Nuvilex has a 1 year low of $0.25 and a 1 year high of $1.51.

Nuvilex (NASDAQ:PMCB) last posted its earnings results on Monday, September 14th. The company reported ($0.54) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.48).

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Nuvilex from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, September 2nd. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

About Nuvilex

Nuvilex, Inc. was a biotechnology company that later changed its name to PharmaCyte Biotech, Inc. and continued to trade under the ticker symbol PMCB. The company focused on developing cellular therapies intended to treat serious diseases, particularly cancer and diabetes. Its primary technology involved encapsulating genetically engineered human cells in proprietary cellulose-based capsules. These cells were designed to produce therapeutic substances inside the body while limiting exposure to healthy tissue.